Naruvein (hydromorphone) / Daiichi Sankyo - LARVOL DELTA

Steady-State Pharmacokinetics of Intravenous Hydromorphone in Japanese Patients with Renal Impairment and Cancer Pain. (PubMed, J Palliat Med) - "No adverse event was reported. Hydromorphone CLss in patients with impaired renal function (moderate and severe) was decreased ∼50% of that of normal renal function."

Journal • PK/PD data • Oncology • Pain • Renal Disease